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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To systematically review the literature and appraise the existing evidence from systematic reviews regarding the effects of interventions,
aimed at changing clinician behaviour, to reduce antibiotic prescribing for ARIs in primary care.
B A C K G R O U N D
Description of the condition
Antibiotic resistance is recognised as a major threat to human
health worldwide (WHO2015). Each year in theUSA, at least two
million people become ill with antibiotic-resistant infections and
at least 23,000people die as a direct result of these infections (CDC
2013). People with infections caused by drug-resistant bacteria are
generally at increased risk of worse clinical outcomes and death,
and consume more healthcare resources than people infected with
the same bacterial species that are not drug-resistant (WHO2015).
Estimates suggest that an additional 10 million deaths may occur
by 2050 from drug-resistant bacterial infections. In addition, by
the same time point, such infections could cost the global economy
aroundUSD100 trillion, through a reduction in overall economic
production as a result of mortality and morbidity in the labour
force (RAR2014). A recent evaluation also identified that previous
research, which estimated the cost of antimicrobial resistance at
USD 55 billion year in the USA, may have underestimated the
cost of antibiotic resistance and that the real cost may be much
higher (Smith 2013).
Antibiotic use inevitably causes antibiotic resistance as the use
of antibiotics naturally selects for pre-existing antibiotic-resistant
populations of bacteria (Spellberg 2013). Globally, human con-
sumptionof antibiotics increased by 36%between2000 and2010,
which was also reflected in European data that indicated increases
in antibiotic prescription (Adriaenssens 2011; Van Boeckel 2014).
In 2013 in the UK, 949.9 tonnes of antibiotics were used for
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both people and animals, with 56% of the total use being for hu-
man consumption (PHE 2013). For an individual patient, recent
antibiotic use is the single most important risk factor for infec-
tion with an antibiotic-resistant bacterial species (Chung 2007;
Malhotra-Kumar 2007). In addition, longer and multiple courses
of antibiotics are associatedwith higher rates of resistance (Costello
2010). In the last few decades, drug companies have invested lit-
tle in the discovery and development of new antimicrobial drugs,
which are urgently needed to help tackle emerging drug-resistant
bacterial strains (Huttner 2013).Whilst efforts to engage the phar-
maceutical industry are needed, it is crucial that strategies to pro-
mote more prudent use of antibiotics are also undertaken.
Various approaches are available to achieve more prudent antibi-
otic prescribing for people. Strategies include promotion of nar-
row-spectrum over broad-spectrum antibiotics, and prescribing
the shortest and clinically effective course. However, the most sig-
nificant component of more prudent prescribing is the reduction
in prescriptions of antibiotics. Most antibiotics are prescribed in
primary care, with the most common indications for antibiotics
being respiratory infections (ARIs) (Goossens 2005; Gulliford
2014; Shapiro 2014). ARIs include community-acquired pneu-
monia, which usually requires antibiotics, and there may be other
presentations (e.g. acute exacerbation of chronic obstructive pul-
monary disease (COPD)) which may also benefit from antibi-
otics. However, these comprise a minority of ARIs seen in primary
care. Whilst antibiotics may be of clinical benefit in a minority of
cases, people often present with acute and self-limiting infections
for which antibiotics offer little or no benefit and increase risk
of harm through adverse events and antibiotic resistance. One-
third fewer children with acute otitis media had pain at day 2 to
3 (number needed to treat for an additional beneficial outcome
(NNTB) = 20) (Venekamp 2015), and the duration of sore throat
and acute bronchitis (cough) was reduced by 12 to 16 hours (NNT
to prevent one sore throat = 21) with antibiotics (Smith 2014;
Spinks 2013). Meanwhile, the risk of vomiting, diarrhoea or rash
increased (number needed to harm (NNTH) = 9 for acute oti-
tis media, and NNTH = 24 for acute bronchitis). As such, the
management of ARIs is a prime area where overprescription of
antibiotics is common and offers potential for clinician-targeted
interventions to change antibiotic-prescribing behaviour.
Description of the interventions
The prescription of an antibiotic is a distinct behaviour which is
performed by a clinician and in which the clinician has ultimate
control. Many interventions designed to target clinicians also fre-
quently target patients or the public, or both, and in doing so,
provide a holistic approach that acknowledges the various stake-
holders involved in antibiotic prescribing and supports each group
in carrying out particular desirable behaviours. However, an an-
tibiotic cannot ultimately be prescribed without the prescribing
clinician’s consent. In this respect, although several factors may
influence the decision to prescribe an antibiotic, such as the pa-
tient presentation and wishes of the patient, the actual outcome of
whether a prescription is written or not depends on the clinician’s
decision. As such it is crucial to understand how interventions
target this specific population. Consequently, in this overview we
will focus on interventions aimed at clinicians to reduce antibiotic
prescribing for people with ARIs in primary care. We included all
ARIs in this definition although we would not expect to identify
interventions to reduce antibiotic prescribing in conditions where
antibiotics may be beneficial, such as pneumonia. We included
the following interventions:
1. educational materials for clinicians: printed, electronic or
audio-visual materials that target the healthcare professional;
2. educational meetings: healthcare professionals attending
conferences, lectures, training courses or workshops;
3. educational outreach visits: healthcare professionals
receiving information from a trained professional in their
practice setting;
4. audit and feedback: any summary of clinical performance
of health care over a specified time period provided to the
healthcare professional;
5. reminders: verbal, written or electronic information
intended to prompt a healthcare professional to recall
information;
6. financial interventions: targeting the healthcare professional
to include financial incentives (e.g. fee-for-service) and financial
penalties (e.g. direct or indirect financial penalty for
inappropriate behaviour);
7. point-of-care tests: equipment for use by healthcare
professionals in their practice setting to provide diagnostic
information to help reduce the uncertainty associated with
clinical diagnosis;
8. communication strategies: any resource targeted at the
healthcare professional which encourages discussion with a
patient about management options including:
i) clinician-delivered patient educational interventions;
ii) improved communication interventions (for clinician-
patient interaction);
iii) shared decision making (as defined by Coxeter 2015);
9. mass media campaigns: targeted at the healthcare
professional at the population level using varied use of
communication; and
10. delayed prescription strategy: any resource targeted at the
healthcare professional that encourages giving a prescription for a
patient to collect or use at a later date than the initial
consultation.
How the intervention might work
A large body of literature has examined the effectiveness of various
types of interventions, including combinations of interventions.
Educationalmaterials for clinicians have been amajor focus.How-
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ever, these assume a knowledge deficit and do not acknowledge
potential barriers to following recommendations in practice. As
such, they are likely to have only a limited effect on behaviour and
are often not enough to initiate significant change (NICE 2008).
On a broader scale, any single intervention is unlikely to have a
major effect on behaviour due to the multiple factors that influ-
ence an antibiotic-prescribing decision. These factors can relate to
the clinical presentation of the illness (e.g. diagnostic uncertainty),
the social influences in a primary care consultation (e.g. patient
expectations for antibiotics) and the environment in which a pre-
scribing decision is made (e.g. clinician workload) (Tonkin-Crine
2011). In order for an intervention to have themaximum effect on
a specific behaviour it must work to address these various mech-
anisms of behaviour change synergistically. Given this, a multi-
faceted approach to developing interventions to change behaviour
seems to have most potential (Arnold 2005). As a result, previous
research has frequently trialled several interventions in combina-
tion rather than testing single interventions alone. The evaluation
of intervention types is therefore complicated and is constrained
by this type of study design.
Why it is important to do this overview
Antibiotic prescribing is a major driver for the development of an-
tibiotic-resistant infections in the community and is common in
the management of ARIs in primary care. The volume of research
and range of proposed interventions aimed at the reduction of
antibiotic prescribing for ARIs is rapidly growing although their
effectiveness at changing behaviour is varied. A number of sys-
tematic reviews have evaluated the effectiveness of individual in-
terventions but this evidence, on all types of intervention, has not
been synthesized. An overview of the research will help identify
the range of interventions in this area and the supporting evidence
to determine which are most effective at changing antibiotic-pre-
scribing behaviour. This overview will provide a synthesis of the
evidence from published systematic reviews on interventions that
target healthcare professional antibiotic prescribing for ARIs. The
overview will bring together all of the high quality systematic re-
views of any clinician-targeted intervention to reduce antibiotic
prescribing for any ARI in primary care, and could be a reference
document for decision makers and clinicians to review the evi-
dence in this area. The results will inform future guidelines and
identify any gaps in the current evidence base.
O B J E C T I V E S
To systematically review the literature and appraise the existing
evidence from systematic reviews regarding the effects of interven-
tions, aimed at changing clinician behaviour, to reduce antibiotic
prescribing for ARIs in primary care.
M E T H O D S
Criteria for considering reviews for inclusion
Types of reviews
In this overview of reviews, we will include all published system-
atic reviews (Cochrane and non-Cochrane) of randomised con-
trolled trials (RCTs) (to include parallel-group, cluster and facto-
rial) testing interventions that aim to decrease antibiotic prescrib-
ing in primary care for acute respiratory infections (ARIs). We will
include reviews that include primary studies of non-RCT designs
but only where RCT data are reported separately. We will include
reviews that include studies from a variety of primary and am-
bulatory care settings (e.g. general practices, out-of-hours centres,
emergency departments).We will also include reviews with studies
that recruited participants from hospital inpatient settings, as well
as primary or ambulatory care settings, providing data from the
latter are reported separately.
Types of participants
We will include reviews that studied interventions targeted at the
antibiotic-prescribing behaviour of clinicians for the treatment of
ARIs in primary care. Healthcare professionals will include any
professional qualified to prescribe antibiotics to people. Primary
care will include all contexts in which outpatients are managed in
the community as the first point of patient contact to include gen-
eral practice and out-of-hours services, inclusive of emergency de-
partments. We will exclude reviews that purely focused on health-
care professionals working in inpatient settings, including hospi-
tals and residential settings such as nursing homes.
Participant populations studied within reviews will include any
participant, of any age, who presented in a primary care context (as
above) with an ARI. ARI is defined as any sudden onset respiratory
infection.
Types of interventions
We will consider all types of interventions targeted at changing
the antibiotic-prescribing behaviour of healthcare professionals for
the management of ARIs in primary care. We will include the fol-
lowing interventions: educational materials for clinicians, educa-
tional meetings, educational outreach visits, audit and feedback,
reminders, financial interventions, point-of-care tests, communi-
cation strategies, mass media campaigns and any other relevant
intervention not covered by the previous categories. We will in-
clude interventions whether they target healthcare professionals
as a single population or healthcare professionals as one of several
groups of interest.
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Types of outcome measures
Primary outcomes
1. Change in antibiotic prescriptions for ARI (total number
prescribed or proportion of participants prescribed antibiotics, to
include a delayed prescription).
Secondary outcomes
1. Prescribing outcomes:
i) proportion of participants with an ARI given an
antibiotic prescription for immediate use;
ii) proportion of participants with an ARI given a delayed
antibiotic prescription;
2. participant outcomes:
i) proportion of participants with an ARI colonised or
infected with antibiotic-resistant bacteria;
ii) adverse events;
iii) symptom duration or severity;
iv) health-related quality of life;
v) participant satisfaction;
vi) any measure of management failure, e.g. re-
consultation for the same illness, hospital or emergency
department attendance; and
3. healthcare resource costs:
i) management costs for any medication for the
treatment of an ARI or associated complications.
Search methods for identification of reviews
We will search the Cochrane Database of Systematic Reviews
(CDSR) to identify all relevant published Cochrane systematic
reviews of interventions to change the antibiotic-prescribing be-
haviour of healthcare professionals in primary care for ARI. In or-
der to identify any other relevant systematic reviews we will search
the following five databases: MEDLINE (from 1946), EMBASE
(from 1974), CINAHL (from 1982), PsychINFO (from 1967),
Web of Science (from 1945). An Information Specialist, in con-
sultation with the review authors and the Cochrane ARI Group
Information Specialist, developed the MEDLINE search strategy
(Appendix 1). We will not apply any language restrictions.
Data collection and analysis
Selection of reviews
Two review authors (STC and KW/OvH/AMcC/MPH) will in-
dependently screen all titles and abstracts received from the liter-
ature searches to identify potentially eligible reviews based on the
following criteria:
1. review included RCTs or parallel-group, factorial or cluster-
RCTs;
2. participants in studies included in the review were people
who presented in primary care settings with ARIs;
3. investigated single or multifaceted interventions whose
primary aim is to reduce antibiotic prescribing by targeting the
behaviour of healthcare professionals; and
4. investigated the effect of the intervention on antibiotic
prescribing when compared with usual care or the control
intervention.
We will obtain full texts of reviews we identify as potentially el-
igible for inclusion. Two review authors (STC and KW/OvH/
AMcC/MPH) will screen full-text papers. We will agree on in-
clusion of reviews by consensus, through discussion with a third
review author where necessary. We will report the review selection
process using the Preferred Reporting Items for Systematic Review
and Meta-Analysis (PRISMA) flow diagram. Authors will list the
excluded reviews (after assessment of full-text articles) and reasons
for exclusion in a ‘Characteristics of excluded reviews’ table.
Data extraction and management
Two review authors (STC and KW/OvH/AMcC/MPH) will in-
dependently extract data on the characteristics of included system-
atic reviews using a standardised data extraction form. The form
will cover the following information:
1. general information (title, authors, study ID);
2. aims and rationale;
3. extent of search (databases searched, restrictions);
4. eligibility criteria (including type of studies included and
whether RCTs reported separately);
5. participants;
6. interventions (type, target population);
7. comparator(s);
8. outcomes assessed; and
9. conclusions and recommendations of the review.
If necessary, we may seek additional information from the au-
thors of included systematic reviews or occasionally from the au-
thors of primary studies included in systematic reviews. Where
data from a given study are included in multiple reviews, we will
report the extent of the overlap between reviews and assess the
impact of this in interpreting the results of the reviews. This will
involve considering how individual studies have been interpreted
by the authors of each systematic review, the number of studies
included in the review and the likely influence of an individual
study on the review findings. If two reviews completely overlap
regarding the studies they include, we will only include one of the
reviews in the overview. Two review authors (STC and KW/OvH/
AMcC/MPH) will discuss which review should contribute data to
the overview based on the outcomes and comparisons explored,
search end date and ’Risk of bias’ assessment (see below). We will
present a summary of the included reviews in a ’Characteristics of
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included reviews’ table (Higgins 2011). This table will include in-
formation on the population studied, interventions, comparison
intervention, outcomes for which data were reported and a brief
description of any limitations of methods used in each review.
Assessment of methodological quality of included
reviews
Reviews will have to meet a minimum quality criteria in order to
be included in the synthesis. Two review authors (STC and KW/
OvH/AMcC/MPH) will independently assess themethodological
quality of each systematic review using the ROBIS tool (Whiting
2016). ROBIS is used to assess the risk of bias in systematic re-
views using three phases. Phase 1 assesses relevance of included
reviews, phase 2 assesses four domains through which bias may
be introduced into an overview and phase 3 assesses the overall
risk of bias in the interpretation of the overview findings (Whiting
2016). We will assess domains in phase 2 as high or low concern
or unclear findings. We will assess phase 3 as either high or low
risk of bias. We will resolve any differences in quality assessment
by discussion, and if necessary we will consult a third review au-
thor.We will exclude systematic reviews for which the ROBIS tool
suggests a high risk of bias. We will note differences in quality
between included reviews and take these into consideration in the
interpretation of the results of reviews and the overall synthesis
reported in this overview.
Two review authors (STC and KW/OvH/AMcC/MPH) will ex-
amine the included reviews for information on eligibility of in-
cluded trials, risk of bias and the results of any meta-analysis per-
formed.Where information is provided by the authors of each sys-
tematic review, we will extract and report this in the overview. We
will make comparisons between reviews about the data reported
to assess whether judgements made about quality of evidence are
similar between reviews. For any included review where an assess-
ment of quality of evidence is not provided, we will perform a
retrospective analysis using the ’Risk of bias’ tool and the Grading
of Recommendations Assessment, Development and Evaluation
(GRADE) tool (Guyatt 2008; Higgins 2011).
Data synthesis
We will provide a narrative synthesis of all the results of the in-
cluded systematic reviews. We will present a summary of data us-
ing an ’Overview of reviews’ table and will give details of reviews
based on all relevant outcomes. Data will include details of the in-
tervention and comparison intervention, effect of the intervention
relative to the control intervention, the number of participants
and studies, quality of the evidence and any other important com-
ments about the review, as suggested in theCochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). If we identify
any sources of heterogeneity based on the characteristics of stud-
ies in included reviews, we will perform a sensitivity analysis and
report a summary table.
Subgroup analyses are dependent on the data available from the
included reviews, where data from RCTs are reported. We aim to
conduct subgroup analyses in the following areas:
1. adults (aged 18 years and over) versus children;
2. placebo versus no intervention; and
3. combined versus single interventions.
We will perform both subgroup and sensitivity analyses in relation
to the primary outcomes and adverse effects only.Wewill carry out
statistical analysis using the Review Manager software (RevMan
2014) where appropriate. We will present results in a ’Summary
of findings’ table (Higgins 2011).
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
The researchers created a Medline (Ovid) Search strategy which was combined with the best balance of sensitiv-
ity and specificity from the Health Information Research Unit at McMaster University (http://hiru.mcmaster.ca/hiru/
HIRU_Hedges_MEDLINE_Strategies.aspx#Reviews).
1. exp Anti-Bacterial Agents/ OR (Antibacterial? or Anti-bacterial? or Antibiotic? or Anti-biotic? or Macrolide? or beta-Lactam? or
Antimicrobial? or Anti-microbial? or Penicillin or Methicillin or ampicillin or azithromycin or Cephalexin).tw.
2. exp Respiratory Tract Infections/ OR ((respiratory OR chest) adj3 (infect* or inflam*)).tw. OR (ARI OR ARTI OR URTI OR
LRTI).tw. OR Nasopharyngitis/ OR (nasopharyngit* or rhinopharyngit*).tw. OR exp Sinusitis/ OR sinusit*.tw. OR (nasosinusit* or
rhinosinusit*).tw. OR Rhinitis/ OR rhinit*.tw. OR (rhinorrhoea or rhinorrhea).tw. OR ((runny or running or discharg* or congest*
or blocked or stuff* or dripping) adj2 (nose* or nasal)).tw. OR exp Pharyngitis/ OR pharyngit*.tw. OR sore throat*.tw. OR (throat*
adj3 (inflam* or infect*)).tw. OR tonsillit*.tw. OR Laryngitis/ OR laryngit*.tw. OR croup.tw. OR (pseudocroup or tracheobronchit*
or laryngotracheobronchit*).tw. OR Bronchitis/ or exp bronchiolitis/ or bronchiolitis, viral/ OR (bronchit* or bronchiolit*).tw. OR
exp Pneumonia/ OR (pneumon* or pleuropneumon* or bronchopneumon*).tw. OR exp Pleurisy/ OR pleurisy.tw. OR Cough/ OR
Sneezing/ OR (cough* or sneez*).tw. OR exp Otitis Media/ OR (otitis media or aom or ome).tw. OR Earache/ OR earache*.tw. OR
Influenza, Human/ OR (influenza* or flu).tw. OR Common Cold/ OR common cold*.tw.
3. expDrugPrescriptions/ORInappropriate prescribing/ORPractice Patterns, Physicians/OR (prescrib*ORprescrip*OR stewardship
OR Antibiotic therapy OR Antibiotic treatment).tw.
4. (Delay OR Delayed OR Reduce OR Reduces OR Reducing OR Reduced OR Discontinue OR Stopping).ti,ab.
5. Ambulatory Care/ OR exp Ambulatory Care Facilities/ OR exp general practice/ OR
exp general practitioners/ OR exp physicians, family/ OR exp physicians, primary care/ OR exp Primary Health Care/ OR exp Office
Visits/ OR Outpatients/ OR (ambulatory adj3 (care or setting? or facilit* or ward? or department? or service?)).ti,ab. OR (practi* or
physician? or doctor? OR Clinician?).ti,ab. OR (primary care OR primary health care OR primary healthcare).ti,ab. OR (after hour?
or afterhour? or “out of hour?” or ooh).ti,ab. OR (clinic? or visit?).ti,ab. OR ((health* OR medical) adj2 (center? or centre?)).ti,ab.
OR outpatient?.ti,ab. OR exp Emergency Service, Hospital/ OR Emergency Medical Services/ OR (emergency adj3 (care or setting?
or facilit* or ward? or department? or service?)).ti,ab.
6. meta-analysis.mp,pt. OR review.pt. OR search*.tw.
7. 1 AND 2 AND 3 AND 4 AND 5 AND 6
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